This concentration was optimized for use in our assay based on VSV infection of A549 cells, and is significantly higher compared to IFN-α2 plasma levels commonly observed in plasma COVID-19 during the acute phase of disease [4]. The gene discussed is IFNA2; the disease is COVID-19.